Related Experiment Videos
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells
Marloes S van Kester1, Jacoba J Out-Luiting, Peter A von dem Borne
1Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Abstract:
Sézary syndrome (Sz) is an aggressive cutaneous CD4(+) T-cell lymphoma with tumor cells (Sz cells) localized in the skin, lymph nodes, and peripheral blood. Using western blotting, we demonstrate the expression of phosphorylated (P)-Stat3 in the Sz-derived cell line Seax, and in freshly isolated tumor cells from Sz patients (n=6). In Vitro overnight culture without exogenous cytokines results in decreased expression of P-Stat3 (n=3), indicating that Stat3 is not constitutively activated. Incubation of the Seax cell line with the Jak/Stat3 inhibitor Cucurbitacin I resulted in a time- and concentration-dependent decrease of P-Stat3 and Stat3. In freshly isolated Sz cells (n=3), Cucurbitacin I induced a concentration-dependent decrease in Stat3 expression whereas P-Stat3 was undetectable. Finally, incubation of freshly isolated Sz cells (n=4) with 30 microM Cucurbitacin I for 6 hours induced apoptosis in the large majority (73-91%) of tumor cells. These data strengthen the notion that activation of Stat3 plays an essential part in the malignant transformation of Sz and provide further rationale for the therapeutical targeting of Stat3 in Sz.
Insights
Sézary syndrome (Sz) involves malignant T-cells expressing phosphorylated Stat3. Inhibiting Stat3 with Cucurbitacin I induced apoptosis in Sz cells, suggesting Stat3 is a therapeutic target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Sézary syndrome (Sz) is an aggressive cutaneous T-cell lymphoma.
- Tumor cells in Sz are found in skin, lymph nodes, and blood.
- The role of Stat3 signaling in Sz pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression and activation of Stat3 in Sézary syndrome.
- To evaluate the effect of Stat3 inhibition on Sz cells.
Main Methods:
- Western blotting to detect phosphorylated Stat3 (P-Stat3) and Stat3 expression.
- In vitro culture of Sz cell lines and primary Sz cells.
- Treatment with Jak/Stat3 inhibitor Cucurbitacin I.
- Apoptosis assays to assess cell death.
Main Results:
- P-Stat3 was detected in Sz cell lines and primary Sz cells.
- Stat3 activation was not constitutive and decreased upon cytokine withdrawal.
- Cucurbitacin I reduced P-Stat3 and Stat3 levels in a time- and dose-dependent manner.
- Cucurbitacin I induced significant apoptosis in primary Sz cells.
Conclusions:
- Stat3 activation is crucial for the malignant transformation in Sézary syndrome.
- Targeting Stat3 with inhibitors like Cucurbitacin I shows therapeutic potential for Sz.
- These findings support Stat3 as a viable therapeutic target in Sézary syndrome treatment.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Intrinsic Apoptotic Pathway
Caspases
Abnormal Proliferation
Negative Regulator Molecules